DE3770481D1 - Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. - Google Patents

Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.

Info

Publication number
DE3770481D1
DE3770481D1 DE8787100203T DE3770481T DE3770481D1 DE 3770481 D1 DE3770481 D1 DE 3770481D1 DE 8787100203 T DE8787100203 T DE 8787100203T DE 3770481 T DE3770481 T DE 3770481T DE 3770481 D1 DE3770481 D1 DE 3770481D1
Authority
DE
Germany
Prior art keywords
carbon atoms
imidazochinazolines
treating
group
nephritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787100203T
Other languages
English (en)
Inventor
C O Daiichi Seiyaku Res Takami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3770481D1 publication Critical patent/DE3770481D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
DE8787100203T 1986-01-10 1987-01-09 Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. Expired - Lifetime DE3770481D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP301986 1986-01-10

Publications (1)

Publication Number Publication Date
DE3770481D1 true DE3770481D1 (de) 1991-07-11

Family

ID=11545619

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787100203T Expired - Lifetime DE3770481D1 (de) 1986-01-10 1987-01-09 Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.

Country Status (7)

Country Link
US (1) US4766126A (de)
EP (1) EP0230234B1 (de)
JP (1) JP2525787B2 (de)
KR (1) KR870006898A (de)
AT (1) ATE64095T1 (de)
DE (1) DE3770481D1 (de)
PH (1) PH23966A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2113115A1 (en) * 1991-07-29 1993-02-18 Vlad E. Gregor Quinazoline derivatives as acetylcholinesterase inhibitors
US5707621A (en) * 1994-08-31 1998-01-13 Chugai Pharmaceutical Co., Ltd. Supression of nephritis-induced protein excretion by anti-IL-8

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604186A (ja) * 1983-06-21 1985-01-10 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン化合物
JPS6028979A (ja) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン類化合物

Also Published As

Publication number Publication date
US4766126A (en) 1988-08-23
PH23966A (en) 1990-01-23
EP0230234A1 (de) 1987-07-29
ATE64095T1 (de) 1991-06-15
KR870006898A (ko) 1987-08-13
JPS62252724A (ja) 1987-11-04
JP2525787B2 (ja) 1996-08-21
EP0230234B1 (de) 1991-06-05

Similar Documents

Publication Publication Date Title
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
ATE89731T1 (de) Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis.
ATE184483T1 (de) Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ATE224372T1 (de) Substituierte 6-alkylphenanthridine
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
DE3770481D1 (de) Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.
DE68900516D1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
ES8202818A1 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
DE3867652D1 (de) N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.
ATE52506T1 (de) Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung.
ES543802A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo n-carbamiloxi sustituido
DK0420224T3 (da) Anthihepatopatisk middel
ATE132038T1 (de) Verbindung zur behandlung von störungen des neurotransmittersystems im gehirn
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
DE3662039D1 (de) Novel diamine derivatives
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE68910282D1 (de) Acylaminoalkylpyridinamide als Inhibitoren der Tumormetastasierung.
ATE227718T1 (de) N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee